🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,187

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

7 results for “Meda AB” Clear

  1. Lamivudina Aurovitas 300 mg comprimidos recubiertos con película EFG

    Meda AB

    Mild Cognitive impairment due to Alzheimer Disease

    phase 2 small molecule active

    1 trial

  2. Olumiant 2 mg film-coated tablets, Maltodextrine powder

    Meda AB

    Human immunodeficency virus

    phase 2 small molecule active

    1 trial

  3. PALONOSETRON, FAMOTIDINE, DEXAMETHASONE PHOSPHATE, Plitidepsin, DEXCHLORPHENIRAMINE, PLACEBO

    Meda AB

    post-COVID-19 Condition (PCC)

    phase 2 small molecule active

    1 trial

  4. Pacritinib

    Meda AB

    Patients with myelofibrosis and platelets counts between 50 - 120 x 10e9/L

    phase 2 small molecule active

    1 trial

  5. Veklury 100 mg powder for concentrate for solution for infusion

    Meda AB

    COVID-10 infection

    phase 2 small molecule active

    1 trial

  6. BENZATHINE BENZYLPENICILLIN , LINEZOLID

    Meda AB

    Syphilis

    approved small molecule active

    1 trial

  7. Biktarvy 50 mg/200 mg/25 mg film-coated tablets, Descovy 200 mg/25 mg film-coated tablets, Delstrigo 100 mg/300 mg/245 mg film-coated tablets, Pifeltro 100 mg film-coated tablets

    Meda AB

    Human Immunodeficiency Virus

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources